The Institute of Chemical Research of Catalonia (ICIQ) is pleased to announce the appointment of Dr. Luis Escobar as Junior Group Leader through ICIQ’s Advanced Tenure Track Programme. In this role, he will establish an innovative research programme centred on hybrid supramolecular systems with biomedical relevance.
The new research group will focus on the design and development of hybrid supramolecular systems that integrate biological scaffolds, such as nucleic acids and peptides, with synthetic host-guest complexes based on macrocyclic receptors. By combining precise molecular design with the programmability of biological scaffolds, his team aims to generate hybrid oligomers and supramolecular nanostructures. These systems will be explored for their long-term potential in health-oriented applications, while advancing the fundamental principles of molecular recognition and self-assembly in complex environments.
Dr Escobar’s recruitment has been made possible thanks to the Severo Ochoa Excellence Grant CEX2024-001469-S, funded by MICIU/AEI/10.13039/501100011033, which supports strategic talent incorporation at ICIQ.
A trajectory shaped by excellence and international experience
Originally from Albacete, Dr. Escobar completed his PhD in Organic Chemistry and Supramolecular Chemistry at ICIQ and the Universitat Rovira i Virgili (URV), including a research stay at the University of Texas at Austin, supported by an FPU Fellowship. He subsequently held postdoctoral positions at the Ludwig Maximilian University (LMU) of Munich, funded by a Humboldt Fellowship, and at the University of Cambridge, where he gained expertise in Chemical Biology, Prebiotic Chemistry, and Polymer Science.
In 2024, he was awarded a Junior Leader Fellowship from the “la Caixa” Foundation and a Ramón y Cajal Fellowship from the Spanish Government, enabling him to return to ICIQ and launch his independent research career. His work has been published in leading journals such as Nature, PNAS, and Chemical Reviews, and he has received several distinctions, including the Extraordinary PhD Award from URV, the Postdoctoral Research Award from the Spanish Royal Society of Chemistry (RSEQ), and recognition as an Emerging Talent in Systems Chemistry.
“I am deeply honoured and genuinely excited to take on the role of Junior Group Leader at ICIQ. This appointment represents a significant milestone in my academic journey and a unique opportunity to consolidate and expand my independent research program within an environment that fosters excellence, creativity, and scientific rigor. ICIQ’s commitment to multidisciplinary collaboration and international impact resonates strongly with my ambition to develop innovative hybrid systems that bridge synthetic and biological chemistry. I look forward to building a dynamic research team, contributing actively to the institute’s scientific community, and helping to shape the next generation of research at the chemistry-biology interface,” states Dr. Escobar.
With this incorporation, ICIQ reinforces its commitment to nurturing emerging scientific talent and advancing frontier research in Organic Chemistry, Supramolecular Chemistry, and Chemical Biology.
La entrada Dr. Luis Escobar appointed as Junior Group Leader at ICIQ se publicó primero en ICIQ.
